Fish-Oil-Derived DHA-mediated Enhancement of Apoptosis in Acute Lymphoblastic Leukemia Cells is Associated with Accumulation of p53, Downregulation of Survivin, and Caspase-3 Activation

References

• Yamagami T, Porada CD, Pardini RS, Zanjani ED, and Almeida-Porada G: Docosahexaenoic acid induces dose dependent cell death in an early undifferentiated subtype of acute myeloid leukemia cell line. Cancer Biol Ther 8, 331–337, 2009.
   PubMed Web of Science ®Google Scholar
• Kato T, Kolenic N, and Pardini RS: Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status. Nutr Cancer 58, 178–187, 2007.
   PubMed Web of Science ®Google Scholar
• Rose DP, Connolly JM, and Meschter CL: Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice. J Natl Cancer Inst 83, 1491–1495, 1991.
   PubMedGoogle Scholar
• Kato T, Hancock RL, Mohammadpour H, McGregor B, Manalo P, et al.: Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice. Cancer Lett 187, 169–177, 2002.
   PubMed Web of Science ®Google Scholar
• Kelavkar UP, Hutzley J, Dhir R, Kim P, Allen KG, et al.: Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Neoplasia 8, 112–124, 2006.
   PubMed Web of Science ®Google Scholar
• Astorg P: Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control 15, 367–386, 2004.
   PubMed Web of Science ®Google Scholar
• Narayanan BA, Narayanan NK, and Reddy BS: Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int J Oncol 119, 1255–1262, 2001.
   Google Scholar
• Chamras H, Ardashian A, Heber D, and Glaspy JA: Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J Nutr Biochem 13, 711–716, 2002.
   PubMed Web of Science ®Google Scholar
• Miura Y, Takahara K, Murata Y, Utsumi K, Tada M, et al.: Docosahexaenoic acid induces apoptosis via the Bax-independent pathway in HL-60 cells. Biosci Biotechnol Biochem 68, 2415–2417, 2004.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Vosseler CA, Weber PC, and Erl W: Docosahexaenoic acid induces apoptosis in proliferating human endothelial cells. J Cell Physiol 204, 881–888, 2005.
   PubMed Web of Science ®Google Scholar
• Chiu LCM, Wong EYL, and Ool VEC: Docosahexaenoic acid modulates different genes in cell cycle and apoptosis to control growth of human leukemia HL-60 cells. Int J Oncol 25, 737–744, 2004.
   PubMed Web of Science ®Google Scholar
• Troeger A, Siepermann M, Escherich G, Meisel R, Willers R, et al.: Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia. Haematologica 92, 1043–1050, 2007.
   PubMed Web of Science ®Google Scholar
• Zhou M, Yeager AM, Smith SD, and Findley HW: Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Blood 85, 1608–1614, 1995.
   PubMed Web of Science ®Google Scholar
• Wattel E, Preudhomme C, Hecquet B, Vanrumbeke M, Quesnel B, et al.: p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood 84, 3148–3157, 1994.
   PubMed Web of Science ®Google Scholar
• Hsiao MH, Yu AL, Yeargin J, Ku D, and Haas M: Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase. Blood 83, 2922–2930, 1994.
   PubMed Web of Science ®Google Scholar
• Fenaux P, Jonveaux P, Quiquandon I, Preudhomme C, Lai JL, Vanrumbeke M, et al.: Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases. Leukemia 6, 42–46, 1992.
   PubMed Web of Science ®Google Scholar
• Marks DI, Kurz BW, Link MP, Ng E, Shuster JJ, et al.: High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis. Blood 87, 1155–1161, 1996.
   PubMed Web of Science ®Google Scholar
• Gustafsson B, Christenson B, Hjalmar V, and Winiarski J: Cellular expression of MDM2 and p53 in childhood leukemias with poor prognosis. Med Pediatr Oncol 34, 117–124, 2000.
   PubMedGoogle Scholar
• Bueso-Ramos CE, Yang Y, deLeon E, McCown P, Stass SA, et al.: The human MDM-2 oncogene is overexpressed in leukemias. Blood 82, 2617–2623, 1993.
   PubMed Web of Science ®Google Scholar
• Siddiqui RA, Harvey KA, Xu Z, Bammerlin EM, Walker C, and Altenburg JD: Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects. Biofactors 37, 399–412, 2011.
   PubMed Web of Science ®Google Scholar
• Toit-Kohn JL, Louw L, and Engelbrecht AM: Docosahexaenoic acid induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and p38 MAPK pathways. J Nutr Biochem 20, 106–114, 2009.
   PubMed Web of Science ®Google Scholar
• Zand H, Rhimipour A, Bakhshayesh M, Shafiee M, Nour Mohammadi I, et al.: Involvement of PPAR-gamma and p53 in DHA-induced apoptosis of Reh cells. Mol Cell Biochem 304, 71–77, 2007.
   PubMed Web of Science ®Google Scholar
• Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, et al.: Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21, 2613–2622, 2002.
   PubMed Web of Science ®Google Scholar
• Hoffman WH, Biade S, Zilfou JT, Chen J, and Murphy M: Transcriptional repression of the antiapoptotic survivin gene by wild type p53. J Biol Chem 277, 3247–3257, 2002.
   PubMed Web of Science ®Google Scholar
• Zhou M, Gu L, Li F, Zhu Y, Woods WG, et al.: DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. J Pharmacol Exp Ther 303, 124–131, 2002.
   PubMed Web of Science ®Google Scholar
• Tyner JW, Jemal AM, Thayer M, Druker BJ, and Chang BH: Targeting survivin and p53 in pediatric acute lymphoblastic leukemia. Leukemia 26, 623–632, 2012.
   PubMed Web of Science ®Google Scholar
• Zhu N, Gu L, Li F, and Zhou M: Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells. Mol Cancer Ther 7, 1101–1109, 2008.
   PubMed Web of Science ®Google Scholar
• Pennati M, Folini M, and Zaffaroni N: Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis 28, 1133–1139, 2007.
   PubMed Web of Science ®Google Scholar
• Altieri DC: Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8, 61–70, 2008.
   PubMed Web of Science ®Google Scholar
• Habermann N, Christian B, Luckas B, Pool-Zobel BL, Lund EK, et al.: Effects of fatty acids on metabolism and cell growth of human colon cell lines of different transformation state. Biofactors 35, 460–467, 2009.
   PubMed Web of Science ®Google Scholar
• Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, et al.: An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and −7. Biochemistry 40, 1117–1123, 2001.
   PubMed Web of Science ®Google Scholar
• Burns CP, Halabi S, Clamon GH, Hars V, Wagner BA, et al.: Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin Cancer Res 5, 3942–3947, 1999.
   PubMed Web of Science ®Google Scholar